It is approved for several forms of systemic mastocytosis, and the company’s pipeline includes an oral KIT inhibitor called ... GH stock is up 48.6% year-to-date. Tempus AI (NASDAQ:TEM) is ...

CHICAGO, January 14, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today introduced a suite ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Tempus AI. Looking at options history for Tempus AI (NASDAQ:TEM) we detected 24 trades. If we consider the specifics ...

Whales with a lot of money to spend have taken a noticeably bearish stance on Tempus AI. Looking at options history for Tempus AI TEM we detected 21 trades. If we consider the specifics of each ...

For the fourth quarter and full-year 2024, Tempus AI announced its preliminary revenue numbers on Jan. 13. Per the announcement, fourth-quarter preliminary revenues were around $200 million ...

Tempus AI (NASDAQ: TEM), a healthcare technology company, saw its stock surge 45% in a week after the company announced the launch of its AI app – Olivia. TEM stock was listed on June 14, 2024 ...

AI medicine company Tempus released a peak at its 2024 financials during yesterday's J.P. Morgan Healthcare Conference, saying its revenue of about $693 million showed 30% growth year over year ...

Situated just off the A1 in Northumberland between Alnwick and Berwick-upon-Tweed, the Tempus is conveniently located to reach by road yet feels right in the middle of nature. It sits on the ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. A whimsical boutique hotel in the Northumberland countryside ...

Tempus AI (NASDAQ:TEM) wasn’t that remarkable compared to most other AI high-fliers in the past year. The stock was very volatile in the past year and declined significantly in December 2024 ...

Tempus AI, Inc. (NASDAQ:TEM – Get Free Report)’s share price fell 3.6% during trading on Thursday following insider selling activity. The company traded as low as $36.72 and last traded at $37.49.

Tempus AI is a leading player in healthcare AI, aiming to deliver personalized treatment suggestions through its proprietary data model. Preliminary Q4 results and 2025 guidance show mixed ...